abstract |
A diagnostic method for predicting quantitatively whether a human tumor will be responsive or resistant (non-responsive) to treatment with the VEGF inhibitor, tivozanib (AV- 951), is disclosed. The test is based on application of an algorithm to measurements of expression levels of the genes in a predictive gene set. |